Leap Therapeutics Inc. (LPTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Leap Therapeutics Inc.

NASDAQ: LPTX · Real-Time Price · USD
0.53
-0.20 (-27.40%)
At close: Oct 03, 2025, 3:59 PM
0.57
6.09%
After-hours: Oct 03, 2025, 07:56 PM EDT

Leap Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
47.25M 70.64M 65.5M 114.92M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
823K 966K 1.71M 383K
Receivables
704K 771K 2.1M 1.19M
Inventory
n/a n/a n/a n/a
Other Current Assets
86K 183K 351K n/a
Total Current Assets
48.04M 71.6M 67.95M 116.87M
Property-Plant & Equipment
262K 262K 689K 495K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.08M 1.23M 2.4M 1.04M
Total Assets
49.12M 72.83M 70.35M 117.91M
Account Payables
4.74M 6.46M 5.66M 4.19M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 416K 432K
Other Current Liabilities
n/a 2.78M 2.21M 2.25M
Total Current Liabilities
14.08M 12.68M 11.22M 9.99M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 262K 37K
Total Liabilities
14.08M 12.68M 11.49M 10.02M
Total Debt
266K 262K 678K 469K
Book Value
35.05M 60.14M 58.87M 107.89M
Book Value Per Share
0.93 2.94 5.20 12.57
Common Stock
38K 26K 99K 88K
Retained Earnings
-467.37M -399.58M -318.17M -263.57M
Comprehensive Income
-120K 106K 128K -267K
Shareholders Equity
35.05M 60.14M 58.87M 107.89M
Total Investments
n/a n/a n/a n/a